Tadashi Maeda
Overview
Explore the profile of Tadashi Maeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyazaki T, Aoki K, Maeda T, Komori K, Yoshizawa S, Ishii Y, et al.
BMC Infect Dis
. 2024 Sep;
24(1):989.
PMID: 39289598
Background: The nosocomial transmission of toxin-producing Clostridioides difficile is a significant concern in infection control. C. difficile, which resides in human intestines, poses a risk of transmission, especially when patients...
2.
Ohtani M, Yoshizawa S, Miyazaki T, Kumade E, Hirayama S, Sakamoto M, et al.
Jpn J Infect Dis
. 2024 Mar;
77(5):281-284.
PMID: 38556300
Japanese guidelines recommend metronidazole (MNZ) and vancomycin (VCM) for non-severe and severe cases of Clostridioides difficile infection (CDI), respectively. In the present study, we investigated the use of CDI antimicrobials...
3.
Mori T, Yoshizawa S, Yamada K, Sato T, Sasaki M, Nakamura Y, et al.
BMC Infect Dis
. 2023 Dec;
23(1):883.
PMID: 38110897
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidis has a unique susceptibility profile, being susceptible to penicillins...
4.
Goto Y, Kenmotsu H, Tamiya M, Murakami S, Kurata T, Yanagitani N, et al.
JTO Clin Res Rep
. 2023 May;
4(5):100508.
PMID: 37250506
Introduction: Lorlatinib is an ALK tyrosine kinase inhibitor approved in Japan for the treatment of advanced + NSCLC. There has been little evidence about lorlatinib efficacy after first-line (1L) alectinib...
5.
Sasaki Y, Sato T, Maeda T, Komatsu F, Kawagoe N, Imai T, et al.
Med Sci Monit
. 2023 May;
29:e940238.
PMID: 37150974
BACKGROUND Given the unavailability of reliable biomarkers for vitamin B₁₂ (VB₁₂) deficiency in clinical settings, the usefulness of the ¹³C-propionate breath test (PBT), utilizing VB₁₂ as a coenzyme of methylmalonyl-CoA...
6.
Maeda T, Zai H, Fukui Y, Kato Y, Kumade E, Watanabe T, et al.
BMC Microbiol
. 2022 Jan;
22(1):27.
PMID: 35033024
Background: The bioactivities of commensal duodenal microbiota greatly influence the biofunction of hosts. We investigated the role of Helicobacter pylori infection in extra-gastroduodenal diseases by determining the impact of H....
7.
Sasaki Y, Komatsu F, Kashima N, Maeda T, Honda Y, Shimada N, et al.
J Gen Fam Med
. 2022 Jan;
23(1):19-23.
PMID: 35004106
Background: Acute appendicitis (AA) in older patients can look different from AA in younger patients. Although it is crucial that primary care physicians can recognize AA in patients of any...
8.
Shigeta T, Sasaki Y, Maeda T, Hanji E, Urita Y
Intern Med
. 2021 Jun;
60(23):3833-3837.
PMID: 34120997
Acquired vitamin B (VB) deficiency is a rare cause of thrombotic microangiopathy (TMA). We experienced an 86-year-old Japanese woman who presented with coma, renal dysfunction, and microangiopathic hemolytic anemia. Although...
9.
Hamada M, Yamaguchi T, Sato A, Ono D, Aoki K, Kajiwara C, et al.
Front Cell Infect Microbiol
. 2021 Apr;
11:602833.
PMID: 33842382
In Japan, Staphylococcal cassette chromosome (SCC) type IV methicillin-resistant (MRSA) is an increasingly prominent cause of bacteremia, but the virulence of most of these strains is unclear. We aimed to...
10.
Maeda T, Kashiwagi K, Yoshizawa S, Sato T, Aoki K, Ishii Y, et al.
Jpn J Infect Dis
. 2021 Mar;
74(6):560-562.
PMID: 33642431
Most coronavirus disease 2019 (COVID-19) cases are mild or asymptomatic, and a substantial minority of patients have severe or critical diseases. There are several reports on the potential risk factors...